ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Phenylacetic Acid → Phorbol

HRID 43335
ノート
印刷プレビュー

反応式

HRID 43335 の反応式
[C:1]([O-:4])(=O)[CH3:2].C([O-])(=[O:7])C.C([O-])(=O)C.C([O-])(=O)C.[Pb+4].C1(CC(O)=O)C=CC=CC=1.N1CC=CN1.N=N.[CH3:35][C@H:36]1[C@:42]2([OH:56])[CH:43]3[C@:48]([OH:54])([CH2:49]C(CO)=[CH:51][C@H:41]2[C@H:40]([C:57]([CH3:59])=[CH2:58])[C:38](=[O:39])[CH2:37]1)[C:46](=[O:47])[C:45]([CH3:55])=[CH:44]3>>[CH3:35][C@H:36]1[C@:42]2([OH:56])[C@H:43]3[C@:48]([OH:54])([CH2:49][C:2]([CH2:1][OH:4])=[CH:51][C@H:41]2[C@@H:40]2[C:57]([CH3:58])([CH3:59])[C@:38]2([OH:39])[C@@H:37]1[OH:7])[C:46](=[O:47])[C:45]([CH3:55])=[CH:44]3
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 5

HCID 999Phenylacetic AcidHCID 123195DiimineHCID 41560032,3-dihydro-1H-pyrazoleHCID 102259583CrotophorboloneHCID 178418268HCID 178418268、化合物2 回

生成物 1

HCID 442070Phorbol

実験手順

Another embodiment is shown in FIG. 8. In this embodiment, the acidic hydrolysis of phorbol produces crotophorbolone, which is then used as the starting material. First, treatment of crotophorbolone with hydrazine in the presence of acetic acid selectively affords the C13 hydrazone (not shown), which without isolation is cyclized to pyrazoline S5a. Oxidation of pyrazalone S5a with lead (IV) tetraacetate gives cyclic diazene S7a, allowing for concomitant direct introduction of a C13 acetate group and a diazene bridge between C13 and C15. Other C13 esters can also be directly introduced with this procedure by using the corresponding lead (IV) carboxylate or related oxidants. Photolysis of cyclic diazene S7a results in the extrusion of nitrogen and reestablishment of the C13-15 cyclopropane bond, providing prostratin in high yield and in a remarkably concise four—step sequence from crotophorbolone, or five steps from phorbol with a 12-16% overall yield, producing over 100 mg of prostratin from a single run. DPP can be made in a similar manner. In this case, the acetate ligands of lead tetraacetate are exchanged by premixing with an excess of phenylacetic acid. The resulting salt induces the oxidative conversion of pyrazoline S5a to diazene S7b. (in 36% yield for three steps from crotophorbolone). Subsequent photolysis affords the natural product and therapeutic lead DPP in 90% yield, or 13% overall yield from phorbol. Details of this embodiment are described below in EXAMPLES 7 and 11.

後処理

  1. customSubsequent photolysis affords the natural product and therapeutic lead DPP in 90% yield, or 13%

出典と根拠

ORDレコード
ord-d390fe90fb204762a5ad2addb1141dd3
出典データセット
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08536378B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート